In the latest Medical Discovery News by UTMB’s David Niesel and Norbert Herzog: Good news awaits hepatitis C patients. In the next few years, new drugs that specifically target the hepatitis C virus, curing a person more quickly without the severe side effects, will become available. Some physicians and patients are even opting to wait for these new drugs rather than endure the current therapy.